Success Metrics

Clinical Success Rate
97.7%

Based on 128 completed trials

Completion Rate
98%(128/131)
Active Trials
8(5%)
Results Posted
22%(28 trials)
Terminated
3(2%)

Phase Distribution

Ph phase_2
9
6%
Ph phase_1
122
81%
Ph phase_3
4
3%
Ph not_applicable
4
3%
Ph phase_4
8
5%
Ph early_phase_1
2
1%

Phase Distribution

124

Early Stage

9

Mid Stage

12

Late Stage

Phase Distribution149 total trials
Early Phase 1First-in-human
2(1.3%)
Phase 1Safety & dosage
122(81.9%)
Phase 2Efficacy & side effects
9(6.0%)
Phase 3Large-scale testing
4(2.7%)
Phase 4Post-market surveillance
8(5.4%)
N/ANon-phased studies
4(2.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

95.5%

128 of 134 finished

Non-Completion Rate

4.5%

6 ended early

Currently Active

8

trials recruiting

Total Trials

150

all time

Status Distribution
Active(12)
Completed(128)
Terminated(6)
Other(4)

Detailed Status

Completed128
unknown4
Active, not recruiting4
Not yet recruiting4
Recruiting4
Terminated3

Development Timeline

Analytics

Development Status

Total Trials
150
Active
8
Success Rate
97.7%
Most Advanced
Phase 4

Trials by Phase

Early Phase 12 (1.3%)
Phase 1122 (81.9%)
Phase 29 (6.0%)
Phase 34 (2.7%)
Phase 48 (5.4%)
N/A4 (2.7%)

Trials by Status

terminated32%
withdrawn32%
unknown43%
active_not_recruiting43%
completed12885%
not_yet_recruiting43%
recruiting43%

Recent Activity

Clinical Trials (150)

Showing 20 of 150 trialsScroll for more
NCT06899061Phase 1

Modular Clinical Pharmacology Study to Evaluate the Drug-drug Interaction Potential and Relative Bioavailability of Saruparib

Active Not Recruiting
NCT07047209Phase 2

Trial of Oral Digoxin in Individuals With Amyotrophic Lateral Sclerosis (ALS)

Completed
NCT07339722Phase 1

A Study of LY4515100 in Healthy Participants

Recruiting
NCT06717269Phase 1

A Single and Multiple Ascending Doses, Relative Bioavailability, Food Effect, and Drug-Drug Interaction Study of NX-5948 in Healthy Volunteers

Completed
NCT07118215Phase 1

A Study to Evaluate the Effects of KarXT on the Drug Levels of Midazolam, Fexofenadine, and Digoxin

Completed
NCT07567781Phase 1

A Phase 1 Study to Assess the Effect of ABBV-722 on Midazolam, Digoxin, Pitavastatin, Metformin, and Sitagliptin Drug Levels in Healthy Adults.

Active Not Recruiting
NCT06701812Phase 2

Digoxin Medulloblastoma Study

Recruiting
NCT07570082Phase 1

Drug-Drug Interaction Study of Atumelnant in Healthy Participants

Active Not Recruiting
NCT04621669Phase 1

Drug-durg Interaction of SHR3680 With Digoxin, Rosuvastatin Calcium and Metformin Hydrochloride

Completed
NCT07321509Phase 4

Digoxin After Acute Heart Failure (DIG-DICA)

Recruiting
NCT06588699Phase 2

Digoxin In NASH (CODIN)

Recruiting
NCT06186622Phase 1

A Drug-Drug Interaction Study of Orforglipron (LY3502970) in Healthy Overweight and Obese Participants

Completed
NCT03783429Phase 4

Digoxin Evaluation in Chronic Heart Failure: Investigational Study In Outpatients in the Netherlands

Completed
NCT02783040Phase 1

Interaction of BI 425809 With Midazolam, Warfarin, Omeprazole and Digoxin

Completed
NCT07502001Phase 1

Influence of HDM1005 on Gastric Emptying and Pharmacokinetics of Metformin, Atorvastatin, Warfarin, and Digoxin

Not Yet Recruiting
NCT07223671Phase 1

Study to Evaluate the Effect of Repotrectinib on the Drug Levels of Transporter and CYP P450 Probe Substrates in Healthy Adult Participants

Completed
NCT07066722Phase 1

A Study to Evaluate VH4524184 Tablet Absorption, Effects of Food, and Interactions With Other Drugs in Healthy Adults

Completed
NCT06575933Phase 1

A Study of Calderasib (MK-1084) With Midazolam and Digoxin in Healthy Participants (MK-1084-009)

Completed
NCT05741372Not Applicable

A Study to Compare How Different Medicines (Rosuvastatin, Digoxin, Metformin, and Furosemide) Are Handled by the Body of Healthy People and People With Liver Cirrhosis

Completed
NCT07215260Phase 1

A Study in Healthy People to Test Whether BI 3000202 Affects How 2 Other Medicines (Rosuvastatin and Digoxin) Are Taken up in the Body

Completed

Drug Details

Intervention Type
DRUG
Total Trials
150